- Home
- ARTV vs GEVO Comparison
ARTV vs GEVO Comparison
Compare ARTV & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTV
- GEVO
- Stock Information
- Founded
- ARTV 2019
- GEVO 2005
- Country
- ARTV United States
- GEVO United States
- Employees
- ARTV N/A
- GEVO N/A
- Industry
- ARTV
- GEVO Major Chemicals
- Sector
- ARTV
- GEVO Industrials
- Exchange
- ARTV NYSE
- GEVO Nasdaq
- Market Cap
- ARTV 275.7M
- GEVO 330.4M
- IPO Year
- ARTV 2024
- GEVO 2011
- Fundamental
- Price
- ARTV $10.86
- GEVO $1.63
- Analyst Decision
- ARTV Strong Buy
- GEVO Buy
- Analyst Count
- ARTV 5
- GEVO 2
- Target Price
- ARTV $21.25
- GEVO $8.63
- AVG Volume (30 Days)
- ARTV 45.7K
- GEVO 3.7M
- Earning Date
- ARTV 11-12-2024
- GEVO 11-07-2024
- Dividend Yield
- ARTV N/A
- GEVO N/A
- EPS Growth
- ARTV N/A
- GEVO N/A
- EPS
- ARTV N/A
- GEVO N/A
- Revenue
- ARTV $2,601,000.00
- GEVO $15,589,000.00
- Revenue This Year
- ARTV N/A
- GEVO N/A
- Revenue Next Year
- ARTV N/A
- GEVO $76.64
- P/E Ratio
- ARTV N/A
- GEVO N/A
- Revenue Growth
- ARTV N/A
- GEVO 16.59
- 52 Week Low
- ARTV $9.68
- GEVO $0.48
- 52 Week High
- ARTV $17.31
- GEVO $3.39
- Technical
- Relative Strength Index (RSI)
- ARTV N/A
- GEVO 50.98
- Support Level
- ARTV N/A
- GEVO $1.43
- Resistance Level
- ARTV N/A
- GEVO $1.58
- Average True Range (ATR)
- ARTV 0.00
- GEVO 0.11
- MACD
- ARTV 0.00
- GEVO 0.03
- Stochastic Oscillator
- ARTV 0.00
- GEVO 82.69
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.
About GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. Its operating segments are the Gevo segment, Renewable Natural Gas Segment, and the Agri-Energy segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure.